Growth differentiation factor 15 (GDF-15) levels associate with lower survival in chronic kidney disease patients with COVID-19
A Galassi, P Ciceri, V Bono, L Magagnoli, M Sala… - Biomedicines, 2022 - mdpi.com
A cytokine storm drives the pathogenesis of severe COVID-19 infection and several
biomarkers have been linked to mortality. Chronic kidney disease (CKD) emerged as a risk …
biomarkers have been linked to mortality. Chronic kidney disease (CKD) emerged as a risk …
[PDF][PDF] High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis …
L Toro, L Michea, A Parra-Lucares… - DOI: https://doi. org …, 2023 - academia.edu
End-stage renal disease (ESRD) patients are a population with high rates of COVID-19 and
mortality. These patients present a low response to anti-SARS-CoV-2 immunization, which is …
mortality. These patients present a low response to anti-SARS-CoV-2 immunization, which is …
High plasma levels of fibroblast growth factor 23 are associated with increased risk of COVID-19 in end-stage renal disease patients on hemodialysis: results of a …
End-stage renal disease (ESRD) patients are a population with high rates of COVID-19 and
mortality. These patients present a low response to anti-SARS-CoV-2 immunization, which is …
mortality. These patients present a low response to anti-SARS-CoV-2 immunization, which is …
Circulating GDF-15 in relation to the progression and prognosis of chronic kidney disease: a systematic review and dose-response meta-analysis
Z Zhou, H Liu, H Ju, H Chen, H Jin, M Sun - European Journal of Internal …, 2023 - Elsevier
Background Patients with chronic kidney disease (CKD) typically exhibit circulating growth
differentiation factor-15 (GDF-15) at high levels. This meta-analysis aimed to evaluate the …
differentiation factor-15 (GDF-15) at high levels. This meta-analysis aimed to evaluate the …
Growth differentiation factor 15 provides prognostic information superior to established cardiovascular and inflammatory biomarkers in unselected patients …
Background: Growth differentiation factor 15 (GDF-15) is a strong prognostic marker in
sepsis and cardiovascular disease (CVD). The prognostic value of GDF-15 in coronavirus …
sepsis and cardiovascular disease (CVD). The prognostic value of GDF-15 in coronavirus …
GDF-15 Levels and Other Laboratory Findings as Predictors of COVID-19 Severity and Mortality: A Pilot Study
L Švitek, D Lišnjić, B Grubišić, M Zlosa, E Schönberger… - Biomedicines, 2024 - mdpi.com
Growth differentiation factor 15 (GDF-15) is a stress-induced cytokine associated with acute
and chronic inflammatory states. This prospective observational study aimed to investigate …
and chronic inflammatory states. This prospective observational study aimed to investigate …
[HTML][HTML] Evaluation of plasma biomarkers to predict major adverse kidney events in hospitalized patients with COVID-19
Rationale & Objective Patients hospitalized with COVID-19 are at increased risk for major
adverse kidney events (MAKE). We sought to identify plasma biomarkers predictive of MAKE …
adverse kidney events (MAKE). We sought to identify plasma biomarkers predictive of MAKE …
GDF-15 predicts in-hospital mortality of critically ill patients with acute kidney injury requiring continuous renal replacement therapy: a multicenter prospective study
Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine. This study
evaluated the association between GDF-15 and in-hospital mortality among patients with …
evaluated the association between GDF-15 and in-hospital mortality among patients with …
Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity
Introduction Growth differentiation factor 15 (GDF-15) was originally described as a stress-
induced cytokine, and a biomarker of aging and cardiovascular diseases. We hypothesized …
induced cytokine, and a biomarker of aging and cardiovascular diseases. We hypothesized …
The predictive markers of severity and mortality in hospitalized hemodialysis patients with COVID‐19 during Omicron epidemic
M Banshodani, H Kawanishi, T Hirai… - Therapeutic …, 2023 - Wiley Online Library
Introduction Predictive markers and prognosis remain unclear in hospitalized hemodialysis
(HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic …
(HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic …
相关搜索
- kidney disease gdf 15
- covid 19 gdf 15
- covid 19 disease patients
- covid 19 lower survival
- plasma levels disease patients
- covid 19 plasma levels
- independent biomarker gdf 15
- increased risk disease patients
- covid 19 kidney events
- covid 19 independent biomarker
- covid 19 increased risk
- hospitalized patients kidney events
- end stage disease patients
- covid 19 severity and mortality
- covid 19 predictive markers
- covid 19 end stage